Domenico Ribatti
University of Bari
965 Papers
6.1K Citations
Domenico Ribatti is an academic researcher from University of Bari. The author has contributed to research in topics: Angiogenesis & Biology. The author has an hindex of 96, co-authored 913 publications. Previous affiliations of Domenico Ribatti include University of Genoa & National Institutes of Health.
Chat about Author
Papers
Polyacrylate/polyacrylate-PEG biomaterials obtained by high internal phase emulsions (HIPEs) with tailorable drug release and effective mechanical and biological properties.
Marco Corti,Enrica Calleri,Sara Perteghella,Anna Ferrara,Roberto Tamma,Chiara Milanese,Delia Mandracchia,Gloria Brusotti,Maria Luisa Torre,Domenico Ribatti,Ferdinando Auricchio,Gabriella Massolini,Giuseppe Tripodo +12 more
TL;DR: The physiochemically characterized materials showed a tailorable curcumin drug release, effective mechanical properties and cell viability and resulted neither pro nor anti-angiogenic as demonstrated in vivo by the chick embryo choriallantoic membrane (CAM) assay.
Bortezomib in the treatment of cancer.
TL;DR: Bortezomib (Velcade, formerly PS-341) represents the first proteasome inhibitor to have shown anti-tumor activity in both solid and haematological malignancies and resulted in accelerated approval by the FDA for the treatment of patients with relapsed refractory disease.
Aquaporins in tumor growth and angiogenesis
Beatrice Nico,Domenico Ribatti +1 more
TL;DR: This review article summarizes literature data concerning the involvement of AQPs in tumor growth, angiogenesis and metastatic process and suggests a potential therapeutic approach by antagonizing their biological activity.
New Model for the Study of Angiogenesis and Antiangiogenesis in the Chick Embryo Chorioallantoic Membrane: The Gelatin Sponge/ Chorioallantoic Membrane Assay
Domenico Ribatti,Anna Gualandris,Maria Bastaki,Angelo Vacca,Monica Iurlaro,Luisa Roncali,Marco Presta +6 more
TL;DR: This study presents a new method for the quantitation of angiogenesis and antiangiogenesis in the chick embryo chorioallantoic membrane (CAM), based on the implantation of gelatin sponges on the top of growing CAM, on day 8 of incubation.
Ghrelin inhibits FGF-2-mediated angiogenesis in vitro and in vivo.
Maria Teresa Conconi,Beatrice Nico,Diego Guidolin,Silvia Baiguera,Raffaella Spinazzi,Piera Rebuffat,Ludwik K. Malendowicz,Angelo Vacca,Gianni Carraro,Pier Paolo Parnigotto,Gastone G. Nussdorfer,Domenico Ribatti +11 more
TL;DR: Findings suggest that ghrelin acts as an angiostatic molecule and indicate that its activity is comparable to that of a well-known angiOSTatic agent, i.e., vinblastine.